文献速递免疫规划

婴儿期诱导HIV免疫的免疫学机制

Immunological mechanisms of inducing HIV immunity in infants.
PubMed 文献 · Vaccine · 2019-11-21

美国国家过敏症和传染病研究所(NIAID)与NIH在2018年西班牙马德里HIVR4P会议期间举办研讨会,讨论婴儿期免疫系统开发HIV广谱中和抗体的潜在优势与独特挑战。会议指出HIV感染儿童比成人更早、更频繁产生广谱中和抗体,婴儿期可能是多剂HIV疫苗的独特窗口期,需进一步研究以在儿童人群中测试候选疫苗。

要点

  • HIV感染儿童较成人更早且更频繁产生广谱中和抗体。
  • 婴儿期免疫系统可能为诱导广谱中和抗体提供优势。
  • 需进一步研究以在儿童人群中测试HIV候选疫苗。

核心结论

  • 安全有效的HIV疫苗仍是抗击HIV大流行的关键需求,尤其要预防婴儿、青少年和年轻成人中的新发感染。
  • 婴儿期免疫系统可能为诱导广谱中和抗体提供优势,HIV感染儿童比成人更早、更频繁产生广谱中和抗体。
  • 进一步理解婴儿期独特免疫系统如何被利用来触发广谱中和抗体谱系以诱导持久、多功能的HIV特异性免疫是必要的。

研究设计与样本

  • 由美国国家过敏症和传染病研究所(NIAID)与美国国立卫生研究院(NIH)资助、与2018年在西班牙马德里举行的HIVR4P会议联合举办的研讨会,题为「婴儿期诱导HIV免疫的免疫学机制」。

主要发现

  • HIV感染儿童比感染成人更早且更频繁地产生广谱中和抗体反应,新兴证据提示成人与儿童中广谱中和抗体谱系的激发路径可能不同。
  • 儿童免疫接种预防终身感染已有先例,婴儿期为实施多剂HIV疫苗提供了独特的机会窗口,而实现保护性免疫很可能需要多剂疫苗。

临床怎么用

  • 作者认为,该策略将包括在临床前和临床研究中在儿童人群中测试有前景的HIV候选疫苗。
  • 作者认为,识别保护性分子标志物的新方法也是指导和加速儿童HIV疫苗开发的关键。

局限性

  • 进一步理解婴儿期独特免疫系统如何被利用来触发广谱中和抗体谱系以诱导持久、多功能的HIV特异性免疫是必要的。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The potential advantages and unique challenges of the early life immune system for the development of HIV-specific broadly neutralizing antibodies were discussed during a workshop entitled "Immunological Mechanisms of Inducing HIV Immunity in Infants" sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) in conjunction with the 2018 HIVR4P Conference held in Madrid, Spain. A safe and effective HIV vaccine remains a critical need in the fight against the HIV pandemic, especially to prevent emerging infections in infants, adolescents, and young adults. To successfully target these populations, a vaccine should ideally induce protective immune responses during childhood. Interestingly, several recent studies highlighting differences in immune responses between adults and children have suggested that the early life immune system could present advantages for the elicitation of broadly neutralizing antibodies (bnAbs), a response highly desired for an HIV vaccine. Notably, HIV-infected children develop bnAbs responses earlier and more frequently than infected adults; with emerging evidence that the pathways of elicitation of bnAb lineages may differ between adults and children. Moreover, there is precedent for the prevention of lifelong infections with pediatric immunization, and early life provides a unique window of opportunity for the administration of a multi-dose HIV vaccine that will likely be needed to achieve protective immunity. Further understanding of how the distinct early life immune system can be harnessed to trigger bnAb lineages for induction of durable and polyfunctional HIV-specific immunity is warranted. This strategy will include testing promising HIV vaccine candidates in pediatric populations in preclinical and clinical studies. Novel approaches to identify molecular markers of protection are also key to guide and accelerate pediatric HIV vaccine development.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fouda GG, De Paris K, Levy O, et al. Immunological mechanisms of inducing HIV immunity in infants. Vaccine. 2019. PMID: 31761501. doi:10.1016/j.vaccine.2019.11.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。